Universal Neuro 3
Payments companies reported to CMS as associated with Universal Neuro 3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Universal Neuro 3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Universal Neuro 3
These are the largest totals companies reported as associated with Universal Neuro 3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Lim | Stanford, CA | Neurological Surgery | $67,125.08 |
| Gary Warburton | Baltimore, MD | Oral & Maxillofacial Surgery | $44,100.57 |
| Arash Khalessi-Hosseini | San Diego, CA | Neurological Surgery | $31,254.00 |
| Vikram Durairaj | Austin, TX | Ophthalmic Plastic and Reconstructive Surgery | $27,985.45 |
| Italo Linfante | Miami, FL | Neuroradiology | $5,706.62 |
| David Wilson | Portage, MI | Oral and Maxillofacial Surgery | $2,700.00 |
| Tyler Kenning | Atlanta, GA | Neurological Surgery | $2,112.50 |
| Amin Kassam | Milwaukee, WI | Neurological Surgery | $2,000.00 |
| Alexander Coon | Baltimore, MD | Neurological Surgery | $1,365.06 |
| Ferdinand Hui | Honolulu, HI | Diagnostic Radiology | $816.66 |
Prescribed Universal Neuro 3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.